NCT02527746: Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy |
|
|
| Completed | 1 | 18 | NA | F-627, Recombinant Human Granulocyte Colony Stimulating Factor (rh G-CSF) Fc fusion protein, EC regimen, Epirubicin + Cyclophosphamide | EVIVE Biotechnology, Fudan University | Neutropenia, Breast Cancer | 12/13 | 12/13 | | |
